Teja Kalidindi

474 total citations
21 papers, 255 citations indexed

About

Teja Kalidindi is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Teja Kalidindi has authored 21 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Teja Kalidindi's work include Prostate Cancer Treatment and Research (10 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Peptidase Inhibition and Analysis (3 papers). Teja Kalidindi is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Peptidase Inhibition and Analysis (3 papers). Teja Kalidindi collaborates with scholars based in United States, Sweden and Finland. Teja Kalidindi's co-authors include Nagavarakishore Pillarsetty, Steven M. Larson, Jason S. Lewis, Darren R. Veach, Michael R. McDevitt, David Ulmert, Daniel L.J. Thorek, Blesida Punzalan, Sven‐Erik Strand and Kei Mizuno and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Teja Kalidindi

20 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teja Kalidindi United States 8 128 120 75 67 28 21 255
Futao Liu China 9 109 0.9× 58 0.5× 92 1.2× 64 1.0× 22 0.8× 35 256
Robert Wodtke Germany 10 68 0.5× 105 0.9× 54 0.7× 87 1.3× 13 0.5× 38 288
Michael Meisenheimer Germany 11 202 1.6× 167 1.4× 128 1.7× 57 0.9× 50 1.8× 16 312
Drishty Satpati India 12 318 2.5× 112 0.9× 186 2.5× 91 1.4× 22 0.8× 50 428
Natsuki Honda Japan 6 276 2.2× 76 0.6× 132 1.8× 46 0.7× 31 1.1× 12 366
Ziping Sun China 13 90 0.7× 76 0.6× 64 0.9× 118 1.8× 35 1.3× 23 307
Koen Vermeulen Belgium 7 142 1.1× 73 0.6× 70 0.9× 85 1.3× 8 0.3× 19 254
Jeroen Verhoeven Belgium 12 116 0.9× 67 0.6× 63 0.8× 138 2.1× 28 1.0× 30 317
Frederic Zoller Germany 11 259 2.0× 167 1.4× 82 1.1× 126 1.9× 9 0.3× 13 367
Mohammad B. Haskali Australia 12 201 1.6× 77 0.6× 104 1.4× 106 1.6× 14 0.5× 39 380

Countries citing papers authored by Teja Kalidindi

Since Specialization
Citations

This map shows the geographic impact of Teja Kalidindi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teja Kalidindi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teja Kalidindi more than expected).

Fields of papers citing papers by Teja Kalidindi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teja Kalidindi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teja Kalidindi. The network helps show where Teja Kalidindi may publish in the future.

Co-authorship network of co-authors of Teja Kalidindi

This figure shows the co-authorship network connecting the top 25 collaborators of Teja Kalidindi. A scholar is included among the top collaborators of Teja Kalidindi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teja Kalidindi. Teja Kalidindi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Imberti, Cinzia, Tran Hoang, Teja Kalidindi, et al.. (2024). CEACAM5-Targeted Immuno-PET in Androgen Receptor–Negative Prostate Cancer. Journal of Nuclear Medicine. 65(7). 1043–1050. 5 indexed citations
2.
Kalidindi, Teja, et al.. (2024). Preclinical Evaluation of [124I]-Sotorasib for the Imaging of Kirsten Rat Sarcoma G12C Mutant Tumors. ACS Pharmacology & Translational Science. 7(12). 3867–3878. 1 indexed citations
3.
Bicak, Mesude, Darren R. Veach, Katharina Lückerath, et al.. (2023). Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response. Molecular Cancer Research. 21(4). 307–315. 2 indexed citations
4.
Bakht, Martin, Yasutaka Yamada, Sheng‐Yu Ku, et al.. (2023). Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer. Nature Cancer. 4(5). 699–715. 58 indexed citations
5.
Sharma, Sahil, Suhasini Joshi, Teja Kalidindi, et al.. (2023). Unraveling the Mechanism of Epichaperome Modulation by Zelavespib: Biochemical Insights on Target Occupancy and Extended Residence Time at the Site of Action. Biomedicines. 11(10). 2599–2599. 5 indexed citations
6.
Bhupathiraju, N. V. S. Dinesh K., et al.. (2023). Targeting Carbohydrate Mimetics of Tetrahydrofuran-Containing Acetogenins to Prostate Cancer. Molecules. 28(7). 2884–2884. 1 indexed citations
7.
Sharma, Sahil, Teja Kalidindi, Suhasini Joshi, et al.. (2022). Synthesis of 124I-labeled epichaperome probes and assessment in visualizing pathologic protein-protein interaction networks in tumor bearing mice. STAR Protocols. 3(2). 101318–101318. 4 indexed citations
8.
Bhupathiraju, N. V. S. Dinesh K., et al.. (2022). Synthesis of carbohydrate analogues of the THF-acetogenin 4-deoxyannomontacin and their cytotoxicity against human prostate cancer cell lines. Carbohydrate Research. 521. 108671–108671. 1 indexed citations
9.
Kalidindi, Teja, Sang Gyu Lee, Goutam Chakraborty, et al.. (2021). A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals. European Journal of Nuclear Medicine and Molecular Imaging. 48(8). 2642–2651. 34 indexed citations
10.
Saha, Nayanendu, Kai Xu, Zhongyu Zhu, et al.. (2021). Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells. Translational Oncology. 15(1). 101265–101265. 12 indexed citations
11.
Chakraborty, Goutam, Rahim Hirani, Subhiksha Nandakumar, et al.. (2021). Significance of targeting the antiapoptotic pathway in castration-sensitive prostate cancer.. Journal of Clinical Oncology. 39(6_suppl). 250–250.
12.
Bicak, Mesude, Katharina Lückerath, Teja Kalidindi, et al.. (2020). Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy. Proceedings of the National Academy of Sciences. 117(26). 15172–15181. 18 indexed citations
13.
Lee, Sanggyu, Teja Kalidindi, Blesida Punzalan, et al.. (2020). γ-Tocotrienol–Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs. Journal of Nuclear Medicine. 62(4). 584–590. 6 indexed citations
14.
Russell, James, Milan Grkovski, Teja Kalidindi, et al.. (2020). Predicting Gemcitabine Delivery by18F-FAC PET in Murine Models of Pancreatic Cancer. Journal of Nuclear Medicine. 62(2). 195–200. 7 indexed citations
15.
Kalidindi, Teja, et al.. (2020). Novel radioiodinated theranostic agent targeting PSMA for Prostate cancer. 61. 383–383. 2 indexed citations
16.
Kalidindi, Teja, Sang Gyu Lee, Blesida Punzalan, et al.. (2020). Effect of reducing specific activity of [177Lu]-DKFZ-PSMA617 on uptake in the tumor, salivary gland and kidney. 61. 230–230. 1 indexed citations
17.
McDevitt, Michael R., Daniel L.J. Thorek, Takeshi Hashimoto, et al.. (2018). Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer. Nature Communications. 9(1). 39 indexed citations
18.
Kalidindi, Teja, Rui Gardner, Michael R. McDevitt, et al.. (2017). In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME). Oncotarget. 8(39). 65917–65931. 16 indexed citations
19.
Kalidindi, Teja, et al.. (2016). Copper-64 labeled liposomes for imaging bone marrow. Nuclear Medicine and Biology. 43(12). 781–787. 20 indexed citations
20.
Madapa, Sudharshan, Ian L. Alberts, Steven Ramsey, et al.. (2016). Tetrahydroprotoberberine alkaloids with dopamine and σ receptor affinity. Bioorganic & Medicinal Chemistry. 24(9). 2060–2071. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Futao Liu Breakdown of academic impact, for papers by Robert Wodtke Breakdown of academic impact, for papers by Michael Meisenheimer Breakdown of academic impact, for papers by Drishty Satpati Breakdown of academic impact, for papers by Natsuki Honda Breakdown of academic impact, for papers by Ziping Sun Breakdown of academic impact, for papers by Koen Vermeulen Breakdown of academic impact, for papers by Jeroen Verhoeven Breakdown of academic impact, for papers by Frederic Zoller Breakdown of academic impact, for papers by Mohammad B. Haskali
Rankless by CCL
2026